Market Overview

Jefferies Downgrades Regeneron Pharmaceuticals, Inc. to Hold, Maintains $179.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for REGN

DateFirmActionFromTo
Mar 2015Chardan CapitalInitiates Coverage onBuy
Feb 2015BernsteinInitiates Coverage onOutperform
Feb 2015Piper JaffrayDowngradesOverweightNeutral

View More Analyst Ratings for REGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (REGN)

Around the Web, We're Loving...